Turner and colleagues evaluated the use of the USPIO (ferumoxtran) as a marker for the detection of macrophages in the angiotensin II (ang II)-infused apolipoprotein E deficient (ApoE−/−) AAA mouse model (45). The gene discussed is APOE; the disease is triple-A syndrome.